Samsung Biologics announced on Dec. 26 that it will participate in the “2024 J.P. Morgan Healthcare Conference (JPMHC)” taking place from Jan. 8 to 11 in San Francisco, California, in the U.S.
John Rim, CEO of Samsung Biologics, is scheduled to present on Jan. 9 at 3:45 p.m. local time in the Grand Ballroom. His presentation, titled “Leap Forward, Beyond the Reach of the Past,” will cover key achievements of 2023 and an outlook for 2024, along with the company’s mid- to long-term vision.
Samsung Biologics’ presentation has been moved forward by a day compared to last year, now on the second day of the conference, reflecting its elevated status. JPMHC is known to schedule main track presentations by industry-leading companies.
During the event, Samsung Biologics plans to meet with investors and potential clients to promote its differentiated global CDMO competitiveness and expand partnerships.